Skip to main content
Clinical Trials/ACTRN12606000164594
ACTRN12606000164594
Recruiting
Not Applicable

A study to assess whether clinical and neurohormal markers can predict the outcome of biphasic versus monsophasic cardioversion for atrial fibrillation.

Christchurch Cardioendocrine Research Group0 sites200 target enrollmentMay 9, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Christchurch Cardioendocrine Research Group
Enrollment
200
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2006
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Christchurch Cardioendocrine Research Group

Eligibility Criteria

Inclusion Criteria

  • Atrial fibrillation or flutter on the waiting list for elective DC cardioversion who are welling to participate and capable of attending follow up appointments.

Exclusion Criteria

  • Any patient who is unable or not welling to consent to be enrolled, and patients who can not attend the follow up appointment.

Outcomes

Primary Outcomes

Not specified

Similar Trials